A new genetically engineered mouse model of choroid plexus carcinoma

Area of Science:

• Neuro-oncology
• Pediatric Cancer Research
• Animal Model Development

Background:

• Choroid plexus carcinomas (CPCs) are aggressive pediatric brain tumors with poor prognoses.
• Effective therapies are limited, highlighting the need for better preclinical models.

Purpose of the Study:

• To create a novel, genetically engineered mouse model for choroid plexus carcinomas.
• To utilize this model for studying CPC pathogenesis and evaluating therapeutic strategies.

Main Methods:

• Genetic engineering of newborn mice to express stabilized c-Myc (MycT58A) and inactivate Trp53 in the choroid plexus.
• Histological, cellular, and gene expression profiling of induced tumors.

Main Results:

• The engineered mice developed aggressive CPCs with complete penetrance within 150 days.
• Tumors histologically resembled human CPCs and were found in all brain ventricles.
• Gene expression analysis revealed significant alterations in cell cycle regulation and DNA damage response pathways.

Conclusions:

• A novel and reliable mouse model for choroid plexus carcinomas has been successfully established.
• This model provides a valuable platform for investigating CPC mechanisms and developing targeted therapies.
• Dysregulation of cell division and DNA checkpoints are potential therapeutic vulnerabilities in CPCs.